
Innospec (IOSP) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
440.8M
Gross Profit
125.1M
28.38%
Operating Income
43.0M
9.75%
Net Income
32.8M
7.44%
EPS (Diluted)
$1.31
Balance Sheet Metrics
Total Assets
1.8B
Total Liabilities
508.9M
Shareholders Equity
1.3B
Debt to Equity
0.40
Cash Flow Metrics
Operating Cash Flow
21.7M
Free Cash Flow
12.7M
Revenue & Profitability Trend
Innospec Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.8B | 1.9B | 2.0B | 1.5B | 1.2B |
Cost of Goods Sold | 1.3B | 1.4B | 1.4B | 1.0B | 850.4M |
Gross Profit | 542.9M | 591.1M | 586.7M | 434.9M | 342.7M |
Gross Margin % | 29.4% | 30.3% | 29.9% | 29.3% | 28.7% |
Operating Expenses | |||||
Research & Development | 47.8M | 41.7M | 38.7M | 37.4M | 30.9M |
Selling, General & Administrative | 314.0M | 387.8M | 360.7M | 267.2M | 237.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 361.8M | 429.5M | 399.4M | 304.6M | 267.9M |
Operating Income | 181.1M | 161.6M | 187.3M | 130.3M | 74.8M |
Operating Margin % | 9.8% | 8.3% | 9.5% | 8.8% | 6.3% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | 1.1M | 1.5M | 1.8M |
Other Non-Operating Income | -149.2M | 10.5M | -1.6M | 5.6M | -33.3M |
Pre-tax Income | 41.2M | 174.4M | 184.6M | 134.4M | 39.7M |
Income Tax | 5.6M | 35.3M | 51.6M | 41.3M | 11.0M |
Effective Tax Rate % | 13.6% | 20.2% | 28.0% | 30.7% | 27.7% |
Net Income | 35.6M | 139.1M | 133.0M | 93.1M | 28.7M |
Net Margin % | 1.9% | 7.1% | 6.8% | 6.3% | 2.4% |
Key Metrics | |||||
EBITDA | 378.5M | 197.3M | 233.8M | 172.8M | 126.1M |
EPS (Basic) | $1.43 | $5.60 | $5.37 | $3.78 | $1.17 |
EPS (Diluted) | $1.42 | $5.56 | $5.32 | $3.75 | $1.16 |
Basic Shares Outstanding | 24932000 | 24851000 | 24787000 | 24647000 | 24563000 |
Diluted Shares Outstanding | 24932000 | 24851000 | 24787000 | 24647000 | 24563000 |
Income Statement Trend
Innospec Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 289.2M | 203.7M | 147.1M | 141.8M | 105.3M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 341.7M | 359.8M | 334.6M | 284.5M | 221.4M |
Inventory | 301.0M | 300.1M | 373.1M | 277.6M | 220.0M |
Other Current Assets | 600.0K | 600.0K | 400.0K | 400.0K | 400.0K |
Total Current Assets | 956.6M | 885.7M | 872.6M | 728.1M | 566.2M |
Non-Current Assets | |||||
Property, Plant & Equipment | 484.4M | 463.2M | 422.8M | 406.9M | 390.0M |
Goodwill | 830.4M | 855.9M | 762.6M | 786.1M | 817.7M |
Intangible Assets | 65.4M | 57.3M | 45.0M | 57.5M | 75.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 13.3M | 16.6M | 13.0M | 11.4M | 15.8M |
Total Non-Current Assets | 778.1M | 821.7M | 731.1M | 842.8M | 831.2M |
Total Assets | 1.7B | 1.7B | 1.6B | 1.6B | 1.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 163.8M | 163.6M | 165.3M | 148.7M | 98.7M |
Short-term Debt | 13.9M | 13.6M | 13.9M | 12.5M | 11.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | 1.2M | - | - | - |
Total Current Liabilities | 371.4M | 371.5M | 405.8M | 336.6M | 252.4M |
Non-Current Liabilities | |||||
Long-term Debt | 31.0M | 31.6M | 31.4M | 23.1M | 29.0M |
Deferred Tax Liabilities | 23.5M | 33.5M | 26.2M | 60.8M | 46.9M |
Other Non-Current Liabilities | 4.2M | 15.9M | 14.8M | 17.7M | 19.4M |
Total Non-Current Liabilities | 147.2M | 186.3M | 157.5M | 201.3M | 200.1M |
Total Liabilities | 518.6M | 557.8M | 563.3M | 537.9M | 452.5M |
Equity | |||||
Common Stock | 300.0K | 300.0K | 300.0K | 300.0K | 300.0K |
Retained Earnings | 1.0B | 1.0B | 924.2M | 822.9M | 758.6M |
Treasury Stock | 93.0M | 94.3M | 95.4M | 90.6M | 93.3M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.2B | 1.1B | 1.0B | 1.0B | 944.9M |
Key Metrics | |||||
Total Debt | 44.9M | 45.2M | 45.3M | 35.6M | 40.8M |
Working Capital | 585.2M | 514.2M | 466.8M | 391.5M | 313.8M |
Balance Sheet Composition
Innospec Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 35.6M | 139.1M | 133.0M | 93.1M | 28.7M |
Depreciation & Amortization | 43.5M | 39.3M | 40.1M | 42.7M | 46.0M |
Stock-Based Compensation | 8.5M | 8.0M | 6.7M | 4.4M | 5.8M |
Working Capital Changes | -22.4M | 50.7M | -104.1M | -41.4M | 61.4M |
Operating Cash Flow | 29.3M | 240.7M | 70.2M | 105.2M | 139.4M |
Investing Activities | |||||
Capital Expenditures | 500.0K | 100.0K | 200.0K | 2.9M | 0 |
Acquisitions | -200.0K | -34.7M | 0 | 0 | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 300.0K | -34.6M | 200.0K | 2.9M | 0 |
Financing Activities | |||||
Share Repurchases | -700.0K | -1.1M | -5.9M | -800.0K | -2.1M |
Dividends Paid | -38.8M | -35.1M | -31.7M | -28.8M | -25.6M |
Debt Issuance | - | - | - | - | 15.0M |
Debt Repayment | 0 | -2.3M | -100.0K | -600.0K | -76.1M |
Financing Cash Flow | -35.3M | -39.0M | -33.7M | -20.0M | -146.8M |
Free Cash Flow | 122.2M | 130.1M | 39.4M | 54.1M | 116.2M |
Net Change in Cash | -5.7M | 167.1M | 36.7M | 88.1M | -7.4M |
Cash Flow Trend
Innospec Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
101.95
Forward P/E
12.54
Price to Book
1.51
Price to Sales
1.09
PEG Ratio
-4.11
Profitability Ratios
Profit Margin
1.08%
Operating Margin
7.96%
Return on Equity
1.55%
Return on Assets
0.53%
Financial Health
Current Ratio
2.87
Debt to Equity
3.79
Beta
1.02
Per Share Data
EPS (TTM)
$0.77
Book Value per Share
$52.03
Revenue per Share
$71.77
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
iosp | 2.0B | 101.95 | 1.51 | 1.55% | 1.08% | 3.79 |
Linde plc | 222.6B | 34.37 | 5.86 | 17.01% | 20.02% | 60.56 |
Sherwin-Williams | 84.2B | 33.46 | 19.05 | 62.43% | 11.03% | 308.57 |
Minerals | 1.9B | 6,055.00 | 1.15 | 0.34% | 0.10% | 58.25 |
Stepan Company | 1.1B | 19.21 | 0.89 | 4.77% | 2.57% | 58.20 |
Ecovyst | 953.7M | 18.41 | 1.37 | -1.96% | -1.91% | 129.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.